Track topics on Twitter Track topics that are important to you
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known whether intensity-modulated radiation therapy is more effective than external-beam radiation therapy in treating patients with early-stage endometrial cancer.
- To compare the incidence of grade 2 or higher acute genitourinary and gastrointestinal toxicity in patients with early-stage endometrial cancer treated with adjuvant pelvic radiotherapy comprising either intensity-modulated radiotherapy or 2-dimensional virtual-simulation planning.
- To compare the incidence of late genitourinary and gastrointestinal toxicity in these patients.
- To determine the feasibility of implementing pelvic nodal irradiation in gynecological cancer.
- To establish an image-guided pathway for gynecological cancer radiotherapy incorporating set-up errors and optimal margins for set-up uncertainty and investigation of effects of bladder filling and rectal preparation protocols on the planning target volume.
- To determine the rate of loco-regional control in these patients.
- To evaluate the quality of life of these patients.
- To determine the rate of disease-free survival of these patients
- To determine the overall survival of these patients.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
- Arm I (control): Patients undergo external-beam pelvic radiotherapy delivered using a 2-dimensional virtual-simulation planned technique followed by vaginal vault brachytherapy.
- Arm II (experimental): Patients undergo external-beam pelvic radiotherapy delivered using intensity-modulated radiotherapy followed by vaginal vault brachytherapy.
Patients complete quality of life questionnaires (EORTC QLQ C30 and EORTC QLQ Cervical Cancer Specific Module CX 24) at baseline, at the end of treatment, at 6 and 12 months, once a year for up to year 5, and then twice a year thereafter for up to year 10.
After completion of study treatment, patients are followed every 3 months for year 1, every 6 month for 1 year, and then once a year for up to 10 years.
Allocation: Randomized, Masking: Open Label, Primary Purpose: Treatment
questionnaire administration, adjuvant therapy, assessment of therapy complications, quality-of-life assessment, brachytherapy, external beam radiation therapy, intensity-modulated radiation therapy, radiation therapy treatment planning/simulation
Saint Luke's Hospital
National Cancer Institute (NCI)
Published on BioPortfolio: 2014-07-24T14:00:39-0400
This randomized phase III trial studies androgen-deprivation therapy and radiation therapy in treating patients with prostate cancer. Androgens can cause the growth of prostate cancer cell...
This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a wa...
This randomized phase III trial studies how well gabapentin plus standard of care work compares to standard of care without Gabapentin in preventing inflammation of the mucous membranes (m...
This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing recurrence in patients with stage IIa-IIIa cancer who have undergone mastectomy. Hyp...
Anti-estrogen (ER) endocrine therapy is an effective treatment strategy in reducing breast cancer mortality. This therapy has a better therapeutic index than chemotherapy but can still affect patients...
There are limited data on the efficacy of adjuvant therapy in ampullary cancer. The aim of this study was to determine whether adjuvant therapy was associated with improved survival for patients with ...
We performed a retrospective study involving 21 patients with chronic disseminate candidiasis (CDC) and 38 patients with candidemia. Neutropenia of >2 weeks' duration was more common in those with CDC...
Adjuvant platinum based chemotherapy is accepted as standard of care in stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in patients with stage IB disease who have ...
Surgery remains an integral part of the treatment of medulloblastoma. We present our experience with repeat surgery for this tumor before initiation of adjuvant therapy.
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
The assessment, treatment, and management of soft tissue injury or dysfunction. Therapy is designed to reduce tension and irritation in affected tissues and may include MASSAGE; muscle stretching, or direct pressure on muscles, connective tissue, and TRIGGER POINTS.
The therapy of the same disease in a patient, with the same agent or procedure repeated after initial treatment, or with an additional or alternate measure or follow-up. It does not include therapy which requires more than one administration of a therapeutic agent or regimen. Retreatment is often used with reference to a different modality when the original one was inadequate, harmful, or unsuccessful.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...